Compare STE & CG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STE | CG |
|---|---|---|
| Founded | 1985 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 18.6B |
| IPO Year | 1992 | 2012 |
| Metric | STE | CG |
|---|---|---|
| Price | $263.47 | $57.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 16 |
| Target Price | ★ $268.25 | $66.29 |
| AVG Volume (30 Days) | 674.3K | ★ 2.7M |
| Earning Date | 11-05-2025 | 10-31-2025 |
| Dividend Yield | 0.96% | ★ 2.45% |
| EPS Growth | 59.39 | ★ 445.01 |
| EPS | ★ 6.97 | 1.78 |
| Revenue | ★ $5,702,415,000.00 | $3,208,300,000.00 |
| Revenue This Year | $9.24 | N/A |
| Revenue Next Year | $6.30 | $20.80 |
| P/E Ratio | $37.72 | ★ $32.05 |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $200.98 | $33.02 |
| 52 Week High | $268.60 | $69.85 |
| Indicator | STE | CG |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 61.74 |
| Support Level | $256.68 | $53.25 |
| Resistance Level | $268.60 | $54.78 |
| Average True Range (ATR) | 4.64 | 1.55 |
| MACD | -0.69 | 0.79 |
| Stochastic Oscillator | 65.59 | 93.17 |
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Carlyle Group is one of the world's largest alternative-asset managers, with $474.1 billion in total AUM, including $332.0 billion in fee-earning AUM, at the end of September 2025. The company has three core business segments: global private equity, which includes its private equity, real estate, infrastructure, and natural resources offerings (with $163.5 billion in total AUM and $101.1 billion in fee-earning AUM), global credit ($208.5 billion/$167.2 billion), and investment/fund solutions, known as Carlyle AlphInvest ($102.1 billion/$63.7 billion). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 3,100 active carry fund investors from 87 countries.